Purchase Order 19GH1026P0402
Award Date 3/25/26
Potential Completion Date 4/10/26
Potential Value $16K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Bureau of Medicine and Surgery awarded a $18,034 firm fixed-price purchase order to Biofire Defense LLC on December 3, 2024, for the BIOFIRE DEFENSE PRODUCT NGDS-ASY-0017. The contract, which requires completion by February 28, 2025, will be performed in Frederick, Maryland. This purchase order represents a tactical procurement from Biofire Defense, a Salt Lake City-based manufacturer specializing in molecular diagnostic technologies and biological agent identification products. No set-aside...
- The Defense Health Agency awarded a $1.54M firm fixed-price purchase order to Biofire Defense LLC on April 15, 2025, for the procurement of a molecular assay analyzer with an ultimate completion date of April 14, 2026. The equipment will be delivered to Camp Pendleton North, California. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001. This...
- The Bureau of Medicine and Surgery awarded a $102,344 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2024, for FilmArray Respiratory Panels 2.1. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, with performance taking place in Peru. Biofire Defense LLC, a Salt Lake City-based limited liability company specializing in molecular diagnostic technologies, has established itself as a key federal vendor for infectious...
- This is a $118,859.44 firm fixed price purchase order award from the United States Marine Corps to Biofire Defense LLC, a limited liability company that manufactures medical and diagnostic equipment. The award is for the delivery of medical and diagnostic equipment, with no set-aside designation. Based on Biofire Defense's background, the equipment provided likely includes its Biofire FilmArray and RAZOR Mk II systems used for biological threat detection, infectious disease testing, and public...
- This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods. The $48,748.00 firm fixed price purchase order is for the delivery of a Respiratory Panel 2.1 IVD with 30 tests. The contract has an ultimate completion date of March 11, 2025. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems,...
- The Defense Health Agency (DHA) awarded a $3.5 million firm fixed-price purchase order to Biofire Defense LLC on September 30, 2024, for molecular diagnostic kits with a completion date of September 29, 2029. This contract, which includes no set-aside designation, will be performed in Bethesda, Maryland. Biofire Defense is a specialized manufacturer of biological agent identification and molecular diagnostic solutions based in Salt Lake City, Utah, known for its FilmArray and RAZOR Mk II systems...
- The Office of Naval Research awarded a $51,110 firm fixed-price purchase order to Biofire Defense LLC on April 2, 2013, for a Film Array System, with an ultimate completion date of May 2, 2013. The contract, which carries no set-aside designation, procures the company's advanced molecular diagnostic technology platform designed to support biodefense and infectious disease detection capabilities. Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies...
- This firm fixed-price purchase order was awarded by the Bureau of Medicine and Surgery, a defense agency within the U.S. Department of the Navy, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $69,801.94 contract is for the delivery of FilmArray Respiratory Panels 2.1, a diagnostic assay used to detect respiratory pathogens. The award has a completion date of September 30, 2025 and does not utilize a set-aside...
- The U.S. Bureau of Medicine and Surgery awarded a $122,832 firm fixed-price purchase order to Biofire Defense LLC on May 24, 2023, for FilmArray Respiratory 2.1 panels, with completion targeted for June 9, 2023. The contract is not designated as a set-aside award and specifies Peru as the place of performance. Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, is a key federal vendor specializing in rapid infectious disease identification products. The...
- This firm-fixed-price purchase order was awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for the delivery of Biofire FilmArray 2.0 complete systems, a molecular diagnostic technology used for rapid pathogen detection and infectious disease testing. The contract has a ceiling value of $39,206.77 and a period of performance ending on April 24, 2020. This contract award is...